Drug Search Results
More Filters [+]

Misonidazole

Alternative Names: misonidazole
Latest Update: 2024-01-31
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: DNA Damager

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: National Cancer Institute (NCI)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Misonidazole

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Hypoxia

Phase 2: Prostate Cancer|Non-Small-Cell Lung Cancer|Hypoxia|Adenocarcinoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT00574353

N/A

Withdrawn

Hypoxia|Colorectal Cancer

2020-12-01

NCI-2012-00107

P2

Unknown status

Non-Small-Cell Lung Cancer

2020-08-17

NCT00606294

N/A

Completed

Head and Neck Cancer|Hypoxia

2019-08-01

HYPOXProstat

P2

Completed

Prostate Cancer|Hypoxia|Adenocarcinoma

2014-11-01

Recent News Events